IgA produced by immortalized B cells reactive to the N-terminal domain of thrombospondin-1 (TSPN) and brain-derived neurotrophic factor (BDNF) recognizes antigens on ovarian cancer cell lines and more effectively inhibits the growth of autologous tumors in vivo compared to control IgA (73). The gene discussed is CD79A; the disease is ovarian carcinoma.